Related Experiment Video
Updated: Jun 6, 2025

05:45
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
9.6K
Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma Progression
Caren Yu-Ju Wu1,2, Yiyun Chen3, Ya-Jui Lin2,4
1Department of Neurosurgery, Keelung Chang Gung Medical Foundation, Keelung, Taiwan.
Cancer Research
|December 2, 2024
Summary
Tumor-associated macrophages in glioblastoma secrete elevated extracellular ATP (eATP), fueling cancer growth. Inhibiting the eATP-P2X7R pathway offers a promising therapeutic strategy for glioblastoma (GBM).
Area of Science:
- Neuro-oncology
- Cancer Immunology
- Cancer Metabolism
Background:
- Glioblastoma (GBM) is an aggressive brain tumor with poor outcomes.
- Tumor-associated microglia and macrophages (TAMs) are key immune cells in the GBM microenvironment.
- TAMs exhibit functional heterogeneity, influencing glioma progression.
Purpose of the Study:
- To investigate the metabolic reprogramming of TAMs in GBM.
- To elucidate the role of TAM-derived extracellular ATP (eATP) in GBM.
- To evaluate the therapeutic potential of targeting the eATP-P2X7R axis.
Main Methods:
- Bulk and single-cell RNA sequencing on GBM patient samples.
- In vitro and in vivo GBM models.
- Analysis of TAM mitochondrial activity, eATP production, and P2X7R signaling.
Main Results:
- TAMs in the GBM core show increased ATP synthase and oxidative phosphorylation.
- GBM cells enhance TAM mitochondrial activity, glucose uptake, and eATP production.
- Elevated eATP activates P2X7R on glioma cells, promoting tumor growth and invasion.
Conclusions:
- TAMs in GBM undergo metabolic changes that increase eATP secretion.
- The eATP-P2X7R axis drives GBM progression.
- Targeting this axis is a potential therapeutic strategy for GBM.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K

